These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15080176)
21. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed. Emmanuel F; Fatima M Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206 [TBL] [Abstract][Full Text] [Related]
22. Changes in injecting practices associated with the use of a medically supervised safer injection facility. Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788 [TBL] [Abstract][Full Text] [Related]
23. The Latin American harm reduction network (RELARD): successes and challenges. Bueno R Int J Drug Policy; 2007 Mar; 18(2):145-7. PubMed ID: 17689358 [No Abstract] [Full Text] [Related]
24. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users. Amundsen EJ Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880 [No Abstract] [Full Text] [Related]
26. "The law is a ass--a idiot". Slobodies HD N J Med; 1997 Nov; 94(11):19-20. PubMed ID: 9385815 [No Abstract] [Full Text] [Related]
27. Hepatitis C prevention and true harm reduction. Madden A; Cavalieri W Int J Drug Policy; 2007 Oct; 18(5):335-7. PubMed ID: 17854719 [No Abstract] [Full Text] [Related]
28. [Russia: sex, drugs, AIDS and the Doctors Without Borders]. Veeken H Ned Tijdschr Geneeskd; 1998 May; 142(20):1158-61. PubMed ID: 9623240 [TBL] [Abstract][Full Text] [Related]
29. The future of harm reduction programmes in Russia. Lancet; 2009 Oct; 374(9697):1213. PubMed ID: 19819371 [No Abstract] [Full Text] [Related]
30. [Can Chagas disease be transmitted by sharing syringes in HIV+ drug addicts?]. Scapellato PG; Bottaro EG; Scapellato JI; Vidal GI Medicina (B Aires); 2006; 66(6):595-6. PubMed ID: 17243211 [No Abstract] [Full Text] [Related]
31. [Services for drug users. Making a difference in many lives]. MedellĂn JM Sidahora; 2005; ():12-7. PubMed ID: 16634157 [No Abstract] [Full Text] [Related]
32. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran. Imani R; Karimi A; Rouzbahani R; Rouzbahani A East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086 [TBL] [Abstract][Full Text] [Related]
33. Thinking ethically about needle and syringe programs. Kleinig J Subst Use Misuse; 2006; 41(6-7):815-25. PubMed ID: 16809168 [TBL] [Abstract][Full Text] [Related]
34. How Ukraine is tackling Europe's worst HIV epidemic. Hurley R BMJ; 2010 Jul; 341():c3538. PubMed ID: 20627980 [No Abstract] [Full Text] [Related]
36. Qualitative evaluation of a peer-based needle syringe programme in Vietnam. Ngo AD; Schmich L; Higgs P; Fischer A Int J Drug Policy; 2009 Mar; 20(2):179-82. PubMed ID: 18242971 [TBL] [Abstract][Full Text] [Related]
37. Rapid scale up of harm reduction in China. Sullivan SG; Wu Z Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354 [TBL] [Abstract][Full Text] [Related]
38. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia. Razali SM Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507 [TBL] [Abstract][Full Text] [Related]